Daiichi Sankyo

Ex-Ranbaxy promoters Malvinder Singh and his brother Shivinder Singh have been held guilty by the Supreme Court of contempt of court in a case filed by Japanese firm Daiichi Sankyo.

The bench headed by Chief Justice Ranjan Gogoi said it will decide on the issue of "contempt of court" only.

The former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh, were told by the Supreme Court today that they could go to jail for disobeying orders to pay dues to Japanese firm Daiichi Sankyo. "We will go into the issue - why you violated our orders. We will send you to jail. We have given you ...

The Supreme Court today asked former Fortis Healthcare promoters and estranged brothers Malvinder Singh and Shivinder Singh to inform it on how they plan to comply with a Rs 3,500 crore arbitration order passed against them by a Singapore tribunal. "You were the flag bearers of the pharmacare industry and it doesn't look good that you are appearing...

The court ordered the presence of two brothers on a plea by the Japanese drug maker Daiichi Sankyo.

RHT Health Trust, which was originally named Religare Health Trust, netted Fortis about 510 million Singapore dollars when it listed in October 2012.

Fortis co-founder Shivinder Mohan Singh said on Friday that his request to withdraw the plea that he filed against his older brother Malvinder Mohan Singh was on Friday accepted by the court but also made it clear that his decision to end business ties with his sibling stands. "The honourable NCLT today granted my request to withdraw the petition o...

Billionaire Shivinder Mohan Singh, co-founder of hospital chain Fortis Healthcare and former Ranbaxy promoter, has filed a case against his elder brother Malvinder Mohan Singh alleging "oppression and mismanagement" at their joint businesses - RHC Holding, Religare and Fortis.

Singh brothers lost the case in Singapore arbitration court that ordered them to pay Rs 3,500 crore to Daiichi Sankyo.

Olmesartan Medoximil tablets, a generic version of Daiichi Sankyo's Benicar, are indicated for the treatment of hypertension, along with other anti-hypertensive agents to lower blood pressure, it added.

Sun Pharmaceutical Industries today said it has launched generic versions of Daiichi Sankyo medicines, used in treatment of high blood pressure, in the US market.

Sun Pharmaceuticals shares jumped over 5 per cent on Friday after the drugmaker's US-based subsidiary Taro Pharma reported strong earnings.

Sun Pharmaceutical Industries on Thursday said the umbrella pact and transaction agreements signed with Daiichi Sankyo and its overseas subsidiaries have been terminated due to divestment of Ranbaxy by the Japanese firm.

Fortis Healthcare shares fell nearly 5 per cent on Friday, while Religare Enterprises shares traded 1 per cent lower. Both Fortis and Religare shares were headed for a fourth straight day of losses.

Billionaire Malvinder Mohan Singh and his younger brother Shivinder Mohan Singh have been asked to pay nearly Rs 2,600 crore in fine to Daiichi Sankyo, for "suppressing and misrepresenting" facts about the 2008 deal involving the sale of controlling stake in Ranbaxy to the Japanese drugmaker.

Ex-Ranbaxy promoters Malvinder Singh and his brother Shivinder Singh have been held guilty by the Supreme Court of contempt of court in a case filed by Japanese firm Daiichi Sankyo.

The bench headed by Chief Justice Ranjan Gogoi said it will decide on the issue of "contempt of court" only.

The former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh, were told by the Supreme Court today that they could go to jail for disobeying orders to pay dues to Japanese firm Daiichi Sankyo. "We will go into the issue - why you violated our orders. We will send you to jail. We have given you ...

The Supreme Court today asked former Fortis Healthcare promoters and estranged brothers Malvinder Singh and Shivinder Singh to inform it on how they plan to comply with a Rs 3,500 crore arbitration order passed against them by a Singapore tribunal. "You were the flag bearers of the pharmacare industry and it doesn't look good that you are appearing...

The court ordered the presence of two brothers on a plea by the Japanese drug maker Daiichi Sankyo.

RHT Health Trust, which was originally named Religare Health Trust, netted Fortis about 510 million Singapore dollars when it listed in October 2012.

Fortis co-founder Shivinder Mohan Singh said on Friday that his request to withdraw the plea that he filed against his older brother Malvinder Mohan Singh was on Friday accepted by the court but also made it clear that his decision to end business ties with his sibling stands. "The honourable NCLT today granted my request to withdraw the petition o...

Billionaire Shivinder Mohan Singh, co-founder of hospital chain Fortis Healthcare and former Ranbaxy promoter, has filed a case against his elder brother Malvinder Mohan Singh alleging "oppression and mismanagement" at their joint businesses - RHC Holding, Religare and Fortis.

Singh brothers lost the case in Singapore arbitration court that ordered them to pay Rs 3,500 crore to Daiichi Sankyo.

Olmesartan Medoximil tablets, a generic version of Daiichi Sankyo's Benicar, are indicated for the treatment of hypertension, along with other anti-hypertensive agents to lower blood pressure, it added.

Sun Pharmaceutical Industries today said it has launched generic versions of Daiichi Sankyo medicines, used in treatment of high blood pressure, in the US market.

Sun Pharmaceuticals shares jumped over 5 per cent on Friday after the drugmaker's US-based subsidiary Taro Pharma reported strong earnings.

Sun Pharmaceutical Industries on Thursday said the umbrella pact and transaction agreements signed with Daiichi Sankyo and its overseas subsidiaries have been terminated due to divestment of Ranbaxy by the Japanese firm.

Fortis Healthcare shares fell nearly 5 per cent on Friday, while Religare Enterprises shares traded 1 per cent lower. Both Fortis and Religare shares were headed for a fourth straight day of losses.

Billionaire Malvinder Mohan Singh and his younger brother Shivinder Mohan Singh have been asked to pay nearly Rs 2,600 crore in fine to Daiichi Sankyo, for "suppressing and misrepresenting" facts about the 2008 deal involving the sale of controlling stake in Ranbaxy to the Japanese drugmaker.